Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

April 05, 2018 07:15 ET | Source: DiaMedica Therapeutics Inc.

DiaMedica Therapeutics Announces Appointment of Scott Kellen as Chief Financial Officer

MINNEAPOLIS, April 05, 2018 (GLOBE NEWSWIRE) -- DiaMedica Therapeutics Inc. (the “Company”) (TSX-V:DMA) (OTCQB:DMCAF) is pleased to announce the appointment of Mr. Scott Kellen as Chief Financial...
March 29, 2018 18:08 ET | Source: DiaMedica Therapeutics Inc.

DiaMedica Therapeutics Announces Final Closing of Private Placement

MINNEAPOLIS, March 29, 2018 (GLOBE NEWSWIRE) -- DiaMedica Therapeutics Inc. (the “Company” and “DiaMedica”) (TSX-V:DMA) (OTCQB:DMCAF) is pleased to announce the successful completion of the second...
March 20, 2018 17:40 ET | Source: DiaMedica Therapeutics Inc.

DiaMedica Therapeutics Announces Closing of Private Placement

MINNEAPOLIS, March 20, 2018 (GLOBE NEWSWIRE) -- DiaMedica Therapeutics Inc. (the “Company”) (TSX-V:DMA) (OTCQB:DMCAF) is pleased to announce the successful completion of the first closing of a...
February 22, 2018 07:00 ET | Source: DiaMedica Therapeutics Inc.

DiaMedica Announces First Enrollment in its PHASE 2 “REMEDY” TRIAL for Acute Ischemic Stroke

DM199 may offer an effective and safe treatment with a significantly longer treatment window (24 hours) compared to the current standard of careREMEDY trial lead by prominent neurologist Dr. Bruce...